How to Buy krsnaa Shares on Fincept?
You can buy Krsnaa Diagnostics Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
NSE: Krsnaa Diagnostics Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept
Stay informed with the latest announcements for Krsnaa, including updates on board meetings and corporate actions.
Krsnaa Diagnostics Limited - https://krsnaadiagnostics.com
Krsnaa Diagnostics Limited provides diagnostic services in India. It offers various diagnostic services, including radiology, pathology, and teleradiology services. The company also provides health packages, such as diagnostic testing packages for diabetes, heart health, liver health, kidney health, thyroid, fatigue, cancer, senior citizen care, bone health, infection screening, fever profiles, etc. It serves its services to public and private hospitals, medical colleges, and community health centers. Krsnaa Diagnostics Limited was incorporated in 2010 and is based in Pune, India.
Krsnaa Diagnostics Limited Share Price Today
835.50
OPEN
835.50
HIGH
817.00
LOW
824.40
CLOSE
52 K
VOLUME
2,853 Cr
Market Cap
137116
Average Volume
Healthcare
Sector
NSI
Exchange
Krsnaa Diagnostics Limited Share Analysis & 2025 Insights
Investor Presentations
| Date | Description | Download |
|---|
SIP
Lumpsum
Invested Amount: ₹
Estimated Returns: ₹
Total Value: ₹
NSE: KRSNAA Stock Actions
Company |
Symbol |
ISIN |
Subject |
Ex Date |
Face Value |
Broadcast Date |
|---|---|---|---|---|---|---|
Krsnaa Diagnostics Limited |
KRSNAA |
INE08LI01020 |
Annual General Meeting |
13 Sep 2024 |
5 |
N/A |
Krsnaa Diagnostics Limited |
KRSNAA |
INE08LI01020 |
Dividend - Rs 2.50 Per Share |
13 Sep 2024 |
5 |
N/A |
Krsnaa Diagnostics Limited |
KRSNAA |
INE08LI01020 |
Dividend - Rs 2.75 Per Share |
15 Sep 2023 |
5 |
N/A |
Krsnaa Diagnostics Limited |
KRSNAA |
INE08LI01020 |
Annual General Meeting |
15 Sep 2023 |
5 |
N/A |
Krsnaa Diagnostics Limited |
KRSNAA |
INE08LI01020 |
Dividend - Rs 2.50 Per Share |
15 Sep 2022 |
5 |
N/A |
NSE: KRSNAA Recent Announcements
Symbol |
Date |
Description |
Industry |
|---|---|---|---|
KRSNAA |
06 Jan 2025, 11:46:16 |
Analysts/Institutional Investor Meet/Con. Call Updates |
N/A |
KRSNAA |
03 Jan 2025, 14:45:42 |
Analysts/Institutional Investor Meet/Con. Call Updates |
N/A |
KRSNAA |
02 Jan 2025, 14:44:44 |
Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
N/A |
KRSNAA |
01 Jan 2025, 12:12:34 |
Analysts/Institutional Investor Meet/Con. Call Updates |
N/A |
KRSNAA |
23 Dec 2024, 11:50:32 |
Trading Window |
N/A |
NSE: KRSNAA Corporate Governance
Name |
Symbol |
Timestamp |
Submission Date |
XBRL Document |
|---|---|---|---|---|
Krsnaa Diagnostics Limited |
KRSNAA |
19 Oct 2024, 16:58:00 |
19 Oct 2024, 16:58:00 |
|
Krsnaa Diagnostics Limited |
KRSNAA |
19 Jul 2024, 12:30:00 |
19 Jul 2024, 12:30:00 |
|
Krsnaa Diagnostics Limited |
KRSNAA |
18 Apr 2024, 14:18:00 |
18 Apr 2024, 14:45:00 |
|
Krsnaa Diagnostics Limited |
KRSNAA |
19 Jan 2024, 12:00:00 |
19 Jan 2024, 12:30:00 |
|
Krsnaa Diagnostics Limited |
KRSNAA |
11 Oct 2023, 18:46:00 |
11 Oct 2023, 19:15:00 |
NSE: KRSNAA Detailed Governance
Category |
Date of Birth |
Date of Initial Appointment |
DIN |
Director Name |
Status |
|---|---|---|---|---|---|
Chairperson & Executive Director |
01 Jun 1974 |
22 Dec 2010 |
01066737 |
Rajendra Mutha |
Active |
Executive Director |
29 Jan 1978 |
29 Jan 2013 |
03600332 |
Pallavi Bhatevara |
Active |
Executive Director |
11 Nov 1980 |
31 Jan 2019 |
07285523 |
Yash Mutha |
Active |
Non-Executive Director,Nominee Director |
28 Sep 1954 |
08 Oct 2020 |
07400417 |
Prem Pradeep |
Active |
Independent Director |
14 Jan 1951 |
25 Apr 2021 |
03595319 |
Chetan Desai |
Active |
NSE: KRSNAA Board Meetings
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
|---|---|---|---|---|---|
KRSNAA DIAGNOSTICS LIMITED has informed the Exchange about Board Meeting to be held on 25-Oct-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 . |
KRSNAA |
N/A |
INE08LI01020 |
Krsnaa Diagnostics Limited |
18 Oct 2024, 18:50:20 |
KRSNAA DIAGNOSTICS LIMITED has informed the Exchange about Board Meeting to be held on 06-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 . |
KRSNAA |
N/A |
INE08LI01020 |
Krsnaa Diagnostics Limited |
30 Jul 2024, 17:31:57 |
KRSNAA DIAGNOSTICS LIMITED has informed the Exchange about Board Meeting to be held on 18-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend. |
KRSNAA |
N/A |
INE08LI01020 |
Krsnaa Diagnostics Limited |
10 May 2024, 11:30:26 |
KRSNAA DIAGNOSTICS LIMITED has informed the Exchange about Board Meeting to be held on 12-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 . |
KRSNAA |
N/A |
INE08LI01020 |
Krsnaa Diagnostics Limited |
01 Feb 2024, 18:36:02 |
KRSNAA DIAGNOSTICS LIMITED has informed the Exchange about Board Meeting to be held on 03-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2023 . |
KRSNAA |
N/A |
INE08LI01020 |
Krsnaa Diagnostics Limited |
27 Oct 2023, 19:16:02 |
NSE: KRSNAA Event Calendar
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
Description |
|---|---|---|---|---|---|---|
Financial Results |
KRSNAA |
- |
INE08LI01020 |
Krsnaa Diagnostics Limited |
18 Oct 2024, 00:00:00 |
To consider and approve the financial results for the quarter and half year ended September 30, 2024 |
Financial Results |
KRSNAA |
- |
INE08LI01020 |
Krsnaa Diagnostics Limited |
30 Jul 2024, 00:00:00 |
To consider and approve the financial results for the period ended June 30, 2024 |
Financial Results/Dividend |
KRSNAA |
- |
INE08LI01020 |
Krsnaa Diagnostics Limited |
10 May 2024, 00:00:00 |
To consider and approve the financial results for the period ended March 31, 2024 and dividend |
Financial Results |
KRSNAA |
- |
INE08LI01020 |
Krsnaa Diagnostics Limited |
01 Feb 2024, 00:00:00 |
To consider and approve the financial results for the period ended December 31, 2023 |
Financial Results |
KRSNAA |
- |
INE08LI01020 |
Krsnaa Diagnostics Limited |
27 Oct 2023, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2023 |
NSE: KRSNAA Balance Sheet Data In (Cr)
| date | period_type | Ordinary Shares Number | Share Issued | Net Debt | Total Debt | Tangible Book Value | Invested Capital | Working Capital | Net Tangible Assets | Capital Lease Obligations | Common Stock Equity | Preferred Stock Equity | Total Capitalization | Total Equity Gross Minority Interest | Minority Interest | Stockholders Equity | Other Equity Interest | Retained Earnings | Additional Paid In Capital | Capital Stock | Common Stock | Preferred Stock | Total Liabilities Net Minority Interest | Total Non Current Liabilities Net Minority Interest | Other Non Current Liabilities | Preferred Securities Outside Stock Equity | Non Current Pension And Other Postretirement Benefit Plans | Tradeand Other Payables Non Current | Non Current Deferred Revenue | Non Current Deferred Taxes Liabilities | Long Term Debt And Capital Lease Obligation | Long Term Capital Lease Obligation | Long Term Debt | Current Liabilities | Other Current Liabilities | Current Debt And Capital Lease Obligation | Current Capital Lease Obligation | Current Debt | Pensionand Other Post Retirement Benefit Plans Current | Payables | Other Payable | Dividends Payable | Total Tax Payable | Accounts Payable | Total Assets | Total Non Current Assets | Other Non Current Assets | Non Current Prepaid Assets | Non Current Deferred Taxes Assets | Investmentin Financial Assets | Available For Sale Securities | Financial Assets Designatedas Fair Value Through Profitor Loss | Goodwill And Other Intangible Assets | Other Intangible Assets | Net PPE | Accumulated Depreciation | Gross PPE | Construction In Progress | Other Properties | Machinery Furniture Equipment | Buildings And Improvements | Properties | Current Assets | Other Current Assets | Prepaid Assets | Inventory | Raw Materials | Other Receivables | Taxes Receivable | Accounts Receivable | Allowance For Doubtful Accounts Receivable | Gross Accounts Receivable | Cash Cash Equivalents And Short Term Investments | Other Short Term Investments | Cash And Cash Equivalents | Cash Equivalents | Cash Financial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30T00:00:00 | quarterly | 32,289,763.00 | 32,289,763.00 | 1,576,900,000.00 | 2,160,880,000.00 | 8,384,380,000.00 | 10,097,310,000.00 | 361,780,000.00 | 8,384,380,000.00 | 471,190,000.00 | 8,407,620,000.00 | 0.00 | 8,435,120,000.00 | 8,407,620,000.00 | 0.00 | 8,407,620,000.00 | 8,246,170,000.00 | 0.00 | 0.00 | 161,450,000.00 | 161,450,000.00 | 0.00 | 4,537,770,000.00 | 726,490,000.00 | 0.00 | 0.00 | 20,530,000.00 | 0.00 | 0.00 | 196,820,000.00 | 348,700,000.00 | 321,200,000.00 | 27,500,000.00 | 3,811,280,000.00 | 35,710,000.00 | 1,812,180,000.00 | 149,990,000.00 | 1,662,190,000.00 | 54,640,000.00 | 928,130,000.00 | 0.00 | 0.00 | 0.00 | 928,130,000.00 | 12,945,390,000.00 | 8,772,330,000.00 | 589,530,000.00 | 0.00 | 24,540,000.00 | 1,236,880,000.00 | 1,236,880,000.00 | 0.00 | 23,240,000.00 | 0.00 | 6,898,140,000.00 | 0.00 | 6,898,140,000.00 | 34,760,000.00 | 6,863,380,000.00 | 0.00 | 0.00 | 0.00 | 4,173,060,000.00 | 178,290,000.00 | 0.00 | 306,870,000.00 | 0.00 | 0.00 | 0.00 | 2,434,720,000.00 | 0.00 | 0.00 | 1,253,180,000.00 | 1,140,390,000.00 | 112,790,000.00 | 0.00 | 0.00 |
| 2024-03-31T00:00:00 | quarterly | 32,289,763.00 | 32,289,763.00 | 1,043,460,000.00 | 1,597,880,000.00 | 8,073,680,000.00 | 9,165,230,000.00 | 1,397,200,000.00 | 8,073,680,000.00 | 530,670,000.00 | 8,098,020,000.00 | 0.00 | 8,153,020,000.00 | 8,098,020,000.00 | 0.00 | 8,098,020,000.00 | 23,950,000.00 | 1,297,010,000.00 | 6,608,130,000.00 | 161,450,000.00 | 161,450,000.00 | 0.00 | 3,621,110,000.00 | 806,450,000.00 | 0.00 | 0.00 | 17,750,000.00 | 205,590,000.00 | 0.00 | 164,300,000.00 | 418,810,000.00 | 363,810,000.00 | 55,000,000.00 | 2,814,660,000.00 | 91,950,000.00 | 1,179,070,000.00 | 166,860,000.00 | 1,012,210,000.00 | 42,260,000.00 | 1,572,310,000.00 | 749,070,000.00 | 50,000.00 | 0.00 | 823,190,000.00 | 11,719,130,000.00 | 7,507,270,000.00 | 591,410,000.00 | 392,360,000.00 | 16,310,000.00 | 151,480,000.00 | 151,470,000.00 | 10,000.00 | 24,340,000.00 | 24,340,000.00 | 6,909,280,000.00 | -2,229,740,000.00 | 9,139,020,000.00 | 462,070,000.00 | 236,080,000.00 | 6,270,380,000.00 | 2,170,490,000.00 | 0.00 | 4,211,860,000.00 | 124,670,000.00 | 148,970,000.00 | 358,070,000.00 | 358,070,000.00 | 190,000,000.00 | 40,000.00 | 1,762,920,000.00 | -54,500,000.00 | 1,817,420,000.00 | 1,751,860,000.00 | 1,728,110,000.00 | 23,750,000.00 | 0.00 | 23,750,000.00 |
| 2024-03-31T00:00:00 | annual | 32,289,763.00 | 32,289,763.00 | 1,043,460,000.00 | 1,597,880,000.00 | 8,073,680,000.00 | 9,165,230,000.00 | 1,397,200,000.00 | 8,073,680,000.00 | 530,670,000.00 | 8,098,020,000.00 | 0.00 | 8,153,020,000.00 | 8,098,020,000.00 | 0.00 | 8,098,020,000.00 | 23,950,000.00 | 1,297,010,000.00 | 6,608,130,000.00 | 161,450,000.00 | 161,450,000.00 | 0.00 | 3,621,110,000.00 | 806,450,000.00 | 0.00 | 0.00 | 17,750,000.00 | 205,590,000.00 | 0.00 | 164,300,000.00 | 418,810,000.00 | 363,810,000.00 | 55,000,000.00 | 2,814,660,000.00 | 91,950,000.00 | 1,179,070,000.00 | 166,860,000.00 | 1,012,210,000.00 | 42,260,000.00 | 1,572,310,000.00 | 749,070,000.00 | 50,000.00 | 0.00 | 823,190,000.00 | 11,719,130,000.00 | 7,507,270,000.00 | 591,410,000.00 | 392,360,000.00 | 16,310,000.00 | 151,480,000.00 | 151,470,000.00 | 10,000.00 | 24,340,000.00 | 24,340,000.00 | 6,909,280,000.00 | -2,229,740,000.00 | 9,139,020,000.00 | 462,070,000.00 | 236,080,000.00 | 6,270,380,000.00 | 2,170,490,000.00 | 0.00 | 4,211,860,000.00 | 124,670,000.00 | 148,970,000.00 | 358,070,000.00 | 358,070,000.00 | 190,000,000.00 | 40,000.00 | 1,762,920,000.00 | -54,500,000.00 | 1,817,420,000.00 | 1,751,860,000.00 | 1,728,110,000.00 | 23,750,000.00 | 0.00 | 23,750,000.00 |
| 2023-09-30T00:00:00 | quarterly | 31,397,613.00 | 31,397,613.00 | 404,310,000.00 | 1,092,180,000.00 | 7,577,990,000.00 | 8,303,750,000.00 | 1,977,720,000.00 | 7,577,990,000.00 | 393,040,000.00 | 7,604,610,000.00 | 0.00 | 7,687,110,000.00 | 7,604,610,000.00 | 0.00 | 7,604,610,000.00 | 7,447,620,000.00 | 0.00 | 0.00 | 156,990,000.00 | 156,990,000.00 | 0.00 | 3,150,130,000.00 | 812,420,000.00 | 0.00 | 0.00 | 7,960,000.00 | 0.00 | 0.00 | 148,720,000.00 | 379,640,000.00 | 297,140,000.00 | 82,500,000.00 | 2,337,710,000.00 | 30,710,000.00 | 712,540,000.00 | 95,900,000.00 | 616,640,000.00 | 27,130,000.00 | 1,059,610,000.00 | 0.00 | 0.00 | 0.00 | 1,059,610,000.00 | 10,754,740,000.00 | 6,439,310,000.00 | 209,450,000.00 | 0.00 | 0.00 | 363,520,000.00 | 363,520,000.00 | 0.00 | 26,620,000.00 | 0.00 | 5,839,720,000.00 | 0.00 | 5,839,720,000.00 | 277,420,000.00 | 5,562,300,000.00 | 0.00 | 0.00 | 0.00 | 4,315,430,000.00 | 160,140,000.00 | 0.00 | 364,300,000.00 | 0.00 | 0.00 | 0.00 | 1,592,930,000.00 | 0.00 | 0.00 | 2,198,060,000.00 | 1,903,230,000.00 | 294,830,000.00 | 0.00 | 0.00 |
| 2023-03-31T00:00:00 | quarterly | 31,397,613.00 | 31,397,613.00 | 0.00 | 324,810,000.00 | 7,359,080,000.00 | 7,552,360,000.00 | 1,237,210,000.00 | 7,359,080,000.00 | 159,810,000.00 | 7,387,360,000.00 | 0.00 | 7,497,360,000.00 | 7,387,360,000.00 | 0.00 | 7,387,360,000.00 | 26,630,000.00 | 814,980,000.00 | 6,379,950,000.00 | 156,990,000.00 | 156,990,000.00 | 0.00 | 1,711,570,000.00 | 719,630,000.00 | 70,000.00 | 0.00 | 12,260,000.00 | 318,680,000.00 | 70,000.00 | 127,650,000.00 | 242,840,000.00 | 132,840,000.00 | 110,000,000.00 | 991,940,000.00 | 22,890,000.00 | 81,970,000.00 | 26,970,000.00 | 55,000,000.00 | 21,510,000.00 | 886,000,000.00 | 264,750,000.00 | 0.00 | 0.00 | 621,250,000.00 | 9,098,930,000.00 | 6,869,770,000.00 | 10,000.00 | 212,560,000.00 | 13,880,000.00 | 1,556,220,000.00 | 1,556,210,000.00 | 10,000.00 | 28,280,000.00 | 28,280,000.00 | 5,027,060,000.00 | -1,530,690,000.00 | 6,557,750,000.00 | 348,600,000.00 | 191,360,000.00 | 4,757,370,000.00 | 1,260,420,000.00 | 0.00 | 2,229,150,000.00 | -10,000.00 | 91,920,000.00 | 250,740,000.00 | 250,740,000.00 | 67,520,000.00 | 40,000.00 | 730,970,000.00 | -51,100,000.00 | 782,070,000.00 | 1,087,960,000.00 | 860,760,000.00 | 227,200,000.00 | 0.00 | 227,200,000.00 |
| 2023-03-31T00:00:00 | annual | 31,397,613.00 | 31,397,613.00 | 0.00 | 324,810,000.00 | 7,359,080,000.00 | 7,552,360,000.00 | 1,237,210,000.00 | 7,359,080,000.00 | 159,810,000.00 | 7,387,360,000.00 | 0.00 | 7,497,360,000.00 | 7,387,360,000.00 | 0.00 | 7,387,360,000.00 | 26,630,000.00 | 814,980,000.00 | 6,379,950,000.00 | 156,990,000.00 | 156,990,000.00 | 0.00 | 1,711,570,000.00 | 719,630,000.00 | 70,000.00 | 0.00 | 12,260,000.00 | 318,680,000.00 | 70,000.00 | 127,650,000.00 | 242,840,000.00 | 132,840,000.00 | 110,000,000.00 | 991,940,000.00 | 22,890,000.00 | 81,970,000.00 | 26,970,000.00 | 55,000,000.00 | 21,510,000.00 | 886,000,000.00 | 264,750,000.00 | 0.00 | 0.00 | 621,250,000.00 | 9,098,930,000.00 | 6,869,770,000.00 | 10,000.00 | 212,560,000.00 | 13,880,000.00 | 1,556,220,000.00 | 1,556,210,000.00 | 10,000.00 | 28,280,000.00 | 28,280,000.00 | 5,027,060,000.00 | -1,530,690,000.00 | 6,557,750,000.00 | 348,600,000.00 | 191,360,000.00 | 4,757,370,000.00 | 1,260,420,000.00 | 0.00 | 2,229,150,000.00 | -10,000.00 | 91,920,000.00 | 250,740,000.00 | 250,740,000.00 | 67,520,000.00 | 40,000.00 | 730,970,000.00 | -51,100,000.00 | 782,070,000.00 | 1,087,960,000.00 | 860,760,000.00 | 227,200,000.00 | 0.00 | 227,200,000.00 |
| 2022-03-31T00:00:00 | annual | 31,397,613.00 | 31,397,613.00 | 0.00 | 409,920,000.00 | 6,820,940,000.00 | 7,100,390,000.00 | 2,131,260,000.00 | 6,820,940,000.00 | 153,620,000.00 | 6,844,090,000.00 | 0.00 | 7,040,310,000.00 | 6,844,090,000.00 | 0.00 | 6,844,090,000.00 | 20,380,000.00 | 271,880,000.00 | 6,390,930,000.00 | 156,990,000.00 | 156,990,000.00 | 0.00 | 1,917,440,000.00 | 707,230,000.00 | 158,240,000.00 | 0.00 | 3,160,000.00 | 277,740,000.00 | 1,250,000.00 | 77,950,000.00 | 330,740,000.00 | 134,520,000.00 | 196,220,000.00 | 1,210,210,000.00 | 147,460,000.00 | 79,180,000.00 | 19,100,000.00 | 60,080,000.00 | 19,810,000.00 | 1,109,410,000.00 | 309,460,000.00 | 0.00 | 26,950,000.00 | 773,000,000.00 | 8,761,530,000.00 | 5,420,060,000.00 | 114,610,000.00 | 226,150,000.00 | 7,880,000.00 | 1,039,630,000.00 | 1,039,620,000.00 | 10,000.00 | 23,150,000.00 | 23,150,000.00 | 4,123,250,000.00 | -1,033,600,000.00 | 5,156,850,000.00 | 289,460,000.00 | 133,230,000.00 | 3,952,750,000.00 | 781,410,000.00 | 0.00 | 3,341,470,000.00 | -80,000.00 | 171,410,000.00 | 91,700,000.00 | 91,700,000.00 | 24,620,000.00 | 56,280,000.00 | 578,730,000.00 | -58,300,000.00 | 637,030,000.00 | 2,418,810,000.00 | 1,534,280,000.00 | 884,530,000.00 | 537,490,000.00 | 347,040,000.00 |
| 2021-03-31T00:00:00 | annual | 31,397,613.00 | 31,397,613.00 | 2,071,040,000.00 | 2,317,790,000.00 | -117,530,000.00 | 2,212,540,000.00 | 643,330,000.00 | 2,306,370,000.00 | 0.00 | -105,250,000.00 | 2,423,900,000.00 | 3,998,190,000.00 | 2,318,650,000.00 | 0.00 | 2,318,650,000.00 | 8,200,000.00 | -412,270,000.00 | 233,190,000.00 | 2,488,850,000.00 | 64,950,000.00 | 2,423,900,000.00 | 3,726,650,000.00 | 1,888,600,000.00 | 0.00 | 0.00 | 5,190,000.00 | 0.00 | 33,030,000.00 | 106,950,000.00 | 1,679,540,000.00 | 0.00 | 1,679,540,000.00 | 1,838,050,000.00 | 0.00 | 638,250,000.00 | 0.00 | 638,250,000.00 | 9,280,000.00 | 1,177,380,000.00 | 391,820,000.00 | 0.00 | 0.00 | 785,560,000.00 | 6,045,300,000.00 | 3,563,920,000.00 | 0.00 | 211,720,000.00 | 0.00 | 26,980,000.00 | 26,980,000.00 | 0.00 | 12,280,000.00 | 12,280,000.00 | 3,177,500,000.00 | -660,590,000.00 | 3,838,090,000.00 | 104,700,000.00 | 95,550,000.00 | 3,056,690,000.00 | 581,150,000.00 | 0.00 | 2,481,380,000.00 | 0.00 | 81,350,000.00 | 72,100,000.00 | 72,100,000.00 | 74,070,000.00 | 0.00 | 724,740,000.00 | -50,000,000.00 | 774,740,000.00 | 1,529,120,000.00 | 1,282,370,000.00 | 246,750,000.00 | 0.00 | 246,750,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 2,228,900,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 150,240,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 150,240,000.00 | 0.00 | 0.00 | 0.00 | 4,951,750,000.00 | 0.00 | 158,360,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: KRSNAA Cash Flow Data In (Cr)
| date | period_type | Free Cash Flow | Repayment Of Debt | Issuance Of Debt | Issuance Of Capital Stock | Capital Expenditure | End Cash Position | Beginning Cash Position | Changes In Cash | Financing Cash Flow | Interest Paid Cff | Cash Dividends Paid | Common Stock Dividend Paid | Net Preferred Stock Issuance | Preferred Stock Issuance | Net Common Stock Issuance | Common Stock Issuance | Net Issuance Payments Of Debt | Net Short Term Debt Issuance | Short Term Debt Issuance | Net Long Term Debt Issuance | Long Term Debt Payments | Long Term Debt Issuance | Investing Cash Flow | Interest Received Cfi | Dividends Received Cfi | Net Investment Purchase And Sale | Sale Of Investment | Purchase Of Investment | Net PPE Purchase And Sale | Sale Of PPE | Purchase Of PPE | Operating Cash Flow | Taxes Refund Paid | Change In Working Capital | Change In Other Current Liabilities | Change In Other Current Assets | Change In Payable | Change In Inventory | Change In Receivables | Other Non Cash Items | Stock Based Compensation | Provisionand Write Offof Assets | Depreciation And Amortization | Amortization Cash Flow | Depreciation | Pension And Employee Benefit Expense | Gain Loss On Investment Securities | Gain Loss On Sale Of PPE | Net Income From Continuing Operations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | -1,695,420,000.00 | -55,000,000.00 | 957,210,000.00 | 231,920,000.00 | -1,938,870,000.00 | 23,750,000.00 | 227,200,000.00 | -203,450,000.00 | 841,870,000.00 | -124,070,000.00 | -86,290,000.00 | 0.00 | 0.00 | 0.00 | 231,920,000.00 | 231,920,000.00 | 902,210,000.00 | 957,210,000.00 | 957,210,000.00 | -55,000,000.00 | -55,000,000.00 | 0.00 | -1,288,770,000.00 | 103,830,000.00 | 0.00 | 537,400,000.00 | 537,400,000.00 | 0.00 | -1,930,000,000.00 | 8,870,000.00 | -1,938,870,000.00 | 243,450,000.00 | -188,020,000.00 | -967,790,000.00 | 135,110,000.00 | -141,230,000.00 | 181,150,000.00 | -107,330,000.00 | -1,035,490,000.00 | -59,220,000.00 | 9,010,000.00 | 3,400,000.00 | 745,470,000.00 | 6,440,000.00 | 739,030,000.00 | 0.00 | 0.00 | 530,000.00 | 700,070,000.00 |
| 2023-03-31T00:00:00 | annual | -650,590,000.00 | -91,300,000.00 | 0.00 | 0.00 | -1,413,600,000.00 | 227,200,000.00 | 884,530,000.00 | -657,330,000.00 | -331,450,000.00 | -53,460,000.00 | -78,490,000.00 | -78,490,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | -91,300,000.00 | 0.00 | 0.00 | -91,300,000.00 | -91,300,000.00 | 0.00 | -1,088,890,000.00 | 101,450,000.00 | 0.00 | 156,920,000.00 | 156,920,000.00 | 0.00 | -1,347,260,000.00 | 66,340,000.00 | -1,413,600,000.00 | 763,010,000.00 | -131,300,000.00 | -355,760,000.00 | 29,350,000.00 | 68,180,000.00 | -149,940,000.00 | -159,040,000.00 | -144,310,000.00 | -87,530,000.00 | 6,730,000.00 | -7,200,000.00 | 537,820,000.00 | 5,880,000.00 | 531,940,000.00 | 0.00 | 0.00 | -1,760,000.00 | 802,010,000.00 |
| 2022-03-31T00:00:00 | annual | -37,950,000.00 | -1,594,310,000.00 | 0.00 | 4,000,000,000.00 | -1,322,190,000.00 | 884,530,000.00 | 246,750,000.00 | 637,780,000.00 | 1,759,900,000.00 | -161,410,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4,000,000,000.00 | 4,000,000,000.00 | -1,893,720,000.00 | -299,410,000.00 | 0.00 | -1,594,310,000.00 | -1,594,310,000.00 | 0.00 | -2,406,360,000.00 | 169,500,000.00 | 0.00 | -1,264,570,000.00 | 0.00 | -1,264,570,000.00 | -1,311,290,000.00 | 10,900,000.00 | -1,322,190,000.00 | 1,284,240,000.00 | -66,290,000.00 | -6,610,000.00 | -72,640,000.00 | -27,460,000.00 | -47,230,000.00 | -19,610,000.00 | 160,330,000.00 | 54,970,000.00 | 12,420,000.00 | 8,300,000.00 | 413,870,000.00 | 3,560,000.00 | 410,310,000.00 | 0.00 | -7,490,000.00 | 2,480,000.00 | 865,100,000.00 |
| 2021-03-31T00:00:00 | annual | 357,180,000.00 | 0.00 | 555,270,000.00 | 7,310,000.00 | -668,400,000.00 | 246,750,000.00 | -475,840,000.00 | 722,590,000.00 | 308,400,000.00 | -254,180,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7,310,000.00 | 7,310,000.00 | 555,270,000.00 | 0.00 | 0.00 | 555,270,000.00 | 0.00 | 555,270,000.00 | -611,390,000.00 | 93,980,000.00 | 0.00 | -56,970,000.00 | 0.00 | -56,970,000.00 | -648,400,000.00 | 20,000,000.00 | -668,400,000.00 | 1,025,580,000.00 | -76,730,000.00 | 148,340,000.00 | -144,280,000.00 | 15,800,000.00 | 404,620,000.00 | -21,430,000.00 | -110,420,000.00 | 140,020,000.00 | 8,200,000.00 | 0.00 | 374,390,000.00 | 0.00 | 374,390,000.00 | -380,000.00 | -2,527,840,000.00 | 5,060,000.00 | 2,954,520,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 302,490,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 302,490,000.00 | 0.00 | 0.00 | 120,000.00 | 0.00 | 0.00 | -72,780,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,770,190,000.00 | 0.00 | 0.00 |
NSE: KRSNAA Income Statement Data In (Cr)
| date | period_type | Tax Effect Of Unusual Items | Tax Rate For Calcs | Normalized EBITDA | Total Unusual Items | Total Unusual Items Excluding Goodwill | Net Income From Continuing Operation Net Minority Interest | Reconciled Depreciation | Reconciled Cost Of Revenue | EBITDA | EBIT | Net Interest Income | Interest Expense | Interest Income | Normalized Income | Net Income From Continuing And Discontinued Operation | Total Expenses | Rent Expense Supplemental | Diluted Average Shares | Basic Average Shares | Diluted EPS | Basic EPS | Diluted NI Availto Com Stockholders | Net Income Common Stockholders | Otherunder Preferred Stock Dividend | Net Income | Minority Interests | Net Income Including Noncontrolling Interests | Net Income Continuous Operations | Tax Provision | Pretax Income | Other Non Operating Income Expenses | Special Income Charges | Other Special Charges | Net Non Operating Interest Income Expense | Total Other Finance Cost | Interest Expense Non Operating | Interest Income Non Operating | Operating Income | Operating Expense | Other Operating Expenses | Depreciation And Amortization In Income Statement | Amortization | Depreciation Income Statement | Selling General And Administration | Selling And Marketing Expense | General And Administrative Expense | Rent And Landing Fees | Gross Profit | Cost Of Revenue | Total Revenue | Operating Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | -0.01 | 0.00 | 158.69 | -0.05 | -0.05 | 56.84 | 74.55 | 206.51 | 158.64 | 84.09 | 0.27 | 14.09 | 16.76 | 56.88 | 56.84 | 549.88 | 8.97 | 3.28 | 3.17 | 0.00 | 0.00 | 56.84 | 56.84 | 0.00 | 56.84 | 0.00 | 56.84 | 56.84 | 13.17 | 70.01 | 0.03 | -0.05 | 0.05 | 0.27 | 2.40 | 14.09 | 16.76 | 69.75 | 343.37 | 134.96 | 74.55 | 0.64 | 73.90 | 13.01 | 2.94 | 10.07 | 8.97 | 413.13 | 206.51 | 619.63 | 619.63 |
| 2023-03-31T00:00:00 | annual | 0.04 | 0.00 | 140.24 | 0.18 | 0.18 | 62.11 | 53.78 | 155.39 | 140.42 | 86.64 | 10.43 | 6.44 | 18.12 | 61.97 | 62.11 | 417.88 | 9.00 | 3.22 | 3.14 | 0.00 | 0.00 | 62.11 | 62.11 | 0.00 | 62.11 | 0.00 | 62.11 | 62.11 | 18.09 | 80.20 | 0.36 | 0.18 | -0.18 | 10.43 | 1.26 | 6.44 | 18.12 | 69.24 | 262.50 | 113.54 | 53.78 | 0.59 | 53.19 | 11.34 | 3.19 | 8.15 | 9.00 | 331.74 | 155.39 | 487.12 | 487.12 |
| 2022-03-31T00:00:00 | annual | -0.05 | 0.00 | 145.01 | -0.25 | -0.25 | 68.39 | 41.39 | 168.29 | 144.76 | 103.37 | -3.58 | 16.86 | 14.91 | 68.58 | 68.39 | 365.11 | 8.43 | 2.99 | 2.99 | 0.00 | 0.00 | 68.39 | 68.39 | 0.00 | 68.39 | 0.00 | 68.39 | 68.39 | 18.12 | 86.51 | 0.00 | -0.25 | 0.25 | -3.58 | 1.63 | 16.86 | 14.91 | 90.34 | 196.82 | 84.29 | 41.39 | 0.36 | 41.03 | 8.25 | 1.81 | 6.44 | 8.43 | 287.16 | 168.29 | 455.45 | 455.45 |
| 2021-03-31T00:00:00 | annual | 94.37 | 0.00 | 105.54 | 252.28 | 252.28 | 184.93 | 37.44 | 191.95 | 357.82 | 320.38 | -13.72 | 24.93 | 12.23 | 27.02 | 184.93 | 339.57 | 7.61 | 3.14 | 3.14 | 0.00 | 0.00 | 184.93 | 184.93 | 0.00 | 184.93 | 0.00 | 184.93 | 184.93 | 110.52 | 295.45 | 0.01 | -0.51 | 0.51 | -13.72 | 1.01 | 24.93 | 12.23 | 56.89 | 147.62 | 61.17 | 37.44 | 1.36 | 36.08 | 11.82 | 1.03 | 10.79 | 7.61 | 204.51 | 191.95 | 396.46 | 396.46 |
FII & DII Data (In Cr)
| Date | FII Gross Purchase | FII Gross Sales | FII Net Purchase / Sales | DII Gross Purchase | DII Gross Sales | DII Net Purchase / Sales |
|---|---|---|---|---|---|---|
| 2025-02-03 | 12,505.92 | 16,464.29 | -3,958.37 | 19,319.48 | 16,611.25 | 2,708.23 |
| 2025-01-30 | 10,513.63 | 15,096.58 | -4,582.95 | 13,934.35 | 11,768.46 | 2,165.89 |
| 2025-01-29 | 7,644.40 | 10,230.83 | -2,586.43 | 12,871.38 | 11,078.67 | 1,792.71 |
| 2025-01-27 | 9,488.57 | 14,504.03 | -5,015.46 | 16,503.43 | 9,861.28 | 6,642.15 |
| 2025-01-24 | 11,230.47 | 13,988.96 | -2,758.49 | 12,835.41 | 10,433.10 | 2,402.31 |
| 2025-01-23 | 13,316.55 | 18,779.07 | -5,462.52 | 14,412.73 | 10,700.18 | 3,712.55 |
| 2025-01-22 | 12,936.64 | 16,962.89 | -4,026.25 | 15,437.18 | 11,796.96 | 3,640.22 |
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Key Metrics
EPS
20.94
P/E
42.191975
P/B
3.39244
Dividend Yield
0.28%
Market Cap
2,852.80 Cr.
Face Value
260.432
Book Value
260.432
ROE
10.16%
EBITDA Growth
165.37 Cr.
Debt/Equity
25.701
Short Term
Subscribe to unlock this feature
Medium Term
Subscribe to unlock this feature
Long Term
Subscribe to unlock this feature
Yearly Stock Performance Heatmap
Latest Updates
Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI
Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...
Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends
"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...
FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore
Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...
Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal
The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...
Apple iPhone SE 4: Price To Features, 11 Things You Need To Know
iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...
Rupee Closed Weaker Against The US Dollar
The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...
Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45
Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...
War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel
The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...
Popular Questions
What is the Market Cap of krsnaa?
The market capitalization of Krsnaa Diagnostics Limited is ₹2,853 Cr as of 05 Feb 2025.
What are the PE and PB ratios of Krsnaa Diagnostics Limited?
The PE and PB ratios of Krsnaa Diagnostics Limited are Not Available and 3.39244 respectively as of 05 Feb 2025.
What is the 52 Week High of Krsnaa Diagnostics Limited?
The 52-week high of Krsnaa Diagnostics Limited is ₹1044 as of 05 Feb 2025.
What is the 52 Week Low of Krsnaa Diagnostics Limited?
The 52-week low of Krsnaa Diagnostics Limited is ₹528.05 as of 05 Feb 2025.
What are the earnings per share (EPS) for Krsnaa Diagnostics Limited?
The Earnings Per Share (EPS) of Krsnaa Diagnostics Limited is ₹20.94 as per the most recent quarterly results available on Fincept.
What is the ROE (Return on Equity) of Krsnaa Diagnostics Limited?
The Return on Equity (ROE) of Krsnaa Diagnostics Limited is 10.16% as per the most recent financial year data. Explore more on Fincept.